BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Bioenvision 

345 Park Avenue
41st Floor
New York  New York  10154-0004  U.S.A.
Phone: 212-750-6700 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Gene Therapy





 Company News
Genzyme Corporation (GENZ) Withdraws Bioenvision (BIVN)'s European Filing of Evoltra(R) in Elderly AML Patients Will Resubmit With New Data from Ongoing Studies 3/19/2008 11:05:27 AM    More...
Genzyme Corporation (GENZ) Gets Bioenvision (BIVN) for $345 Million 10/23/2007 11:47:02 AM    More...
Delaware Court Approves Bioenvision (BIVN) and Genzyme Corporation (GENZ) Joint Petition Special Meeting to be Reconvened on October 22 10/11/2007 11:24:40 AM    More...
Bioenvision (BIVN) and Genzyme Corporation (GENZ) File Petition in Delaware Court 10/10/2007 10:25:35 AM    More...
Bioenvision (BIVN) and Genzyme Corporation (GENZ) (Jobs) Seek to Reopen Vote on Merger 10/10/2007 7:03:08 AM    More...
Bioenvision (BIVN) Adjourns Special Meeting of Stockholders 10/5/2007 12:21:26 PM    More...
Bioenvision (BIVN) Final Vote to Take Place at October 5 Special Meeting of Stockholders 10/5/2007 10:41:49 AM    More...
Genzyme Corporation (GENZ) Affirms Purchase Price for Bioenvision (BIVN) at $5.60 Per Outstanding Share 9/27/2007 10:57:13 AM    More...
Bioenvision (BIVN) Provides Evoltra® (clofarabine) Regulatory Update 8/20/2007 4:29:27 PM    More...
Bioenvision (BIVN) Says Securities Class Action Litigation Without Merit 7/27/2007 11:40:35 AM    More...
12345678910...